EXCHANGE TRADED CONCEPTS, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 298 filers reported holding HAEMONETICS CORP in Q1 2021. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.

Quarter-by-quarter ownership
EXCHANGE TRADED CONCEPTS, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q4 2023$570,266
-4.5%
6,6690.0%0.02%
-11.8%
Q3 2023$597,409
+132.5%
6,669
+72.9%
0.02%
+112.5%
Q2 2021$257,000
-34.4%
3,857
+9.2%
0.01%
-46.7%
Q1 2021$392,000
-16.9%
3,532
-11.2%
0.02%
-31.8%
Q4 2020$472,000
+42.6%
3,978
+4.7%
0.02%
+15.8%
Q3 2020$331,000
+26.3%
3,798
+29.8%
0.02%
-55.8%
Q2 2020$262,0002,9250.04%
Other shareholders
HAEMONETICS CORP shareholders Q1 2021
NameSharesValueWeighting ↓
Iron Triangle Partners LP 330,000$36,633,0004.66%
BEACONLIGHT CAPITAL, LLC 156,395$17,361,0002.80%
Bridge City Capital, LLC 48,011$5,330,0001.77%
Summit Creek Advisors LLC 121,362$13,472,0001.61%
Sivik Global Healthcare LLC 25,000$2,775,0001.01%
ANCHOR CAPITAL ADVISORS LLC 412,218$45,760,0000.97%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 69,655$7,732,0000.90%
Orbimed Advisors 852,000$94,581,0000.88%
LONDON CO OF VIRGINIA 1,057,738$117,420,0000.67%
WEXFORD CAPITAL LP 40,138$4,456,0000.66%
View complete list of HAEMONETICS CORP shareholders